TuHURA Biosciences, Inc.: Form 10-Q for the period ended Dec 31, 2014
Filed with the SEC on Feb 12, 2015 and accepted by EDGAR at Feb 12, 2015, 08:12 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2014-10-01 to 2014-12-31 | −$612.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2014-07-01 to 2014-12-31 | −$1.3m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 6 months2014-07-01 to 2014-12-31 | −$2.1k | us-gaap:InterestExpense |
| Net income | 3 months2014-10-01 to 2014-12-31 | $1.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2014-07-01 to 2014-12-31 | $2.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2014-07-01 to 2014-12-31 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2014-07-01 to 2014-12-31 | $0.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-10-01 to 2014-12-31 | 37,798,183 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2014-07-01 to 2014-12-31 | 37,125,074 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Cash and equivalents | At period end2014-12-31 | $4.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2014-12-31 | $4.1m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $294.2k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $2.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-12-31 | $2.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001013762-15-000152. Last ingested by Listed: Nov 6, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.